GMO Special Opportunities Fund Class VI (GSOFX), a series of GMO Trust managed by Grantham, Mayo, Van Otterloo & Co. LLC (GMO), seeks positive total return through investments in undervalued securities identified via fundamental analysis. Headquartered in Boston, Massachusetts, the fund, part of GMO's offerings since the firm's founding in 1977, employs a flexible strategy across global equities, fixed income, derivatives, and commodities to exploit market inefficiencies and trading discounts to intrinsic value. It targets institutional investors with a minimum investment typically starting at $750,000, operating primarily in U.S. markets while pursuing opportunities worldwide.
The fund's core investment strategies encompass long and short positions in equities, fixed income securities including high yield and emerging market debt, derivatives such as futures, options, swaps, and forward contracts on securities, commodities, currencies, interest rates, and indices; it also invests in exchange-traded funds (ETFs), asset-backed securities, and other structured products to achieve absolute returns with low correlation to traditional benchmarks. GMO's bottom-up security selection emphasizes securities trading below fundamental fair value, complemented by top-down sector allocation in fragmented markets like structured finance.
Recent developments include GMO's expansion of its exchange-traded fund lineup in October 2024 with launches of GMO International Quality ETF (QLTI), GMO U.S. Value ETF (GMOV), and GMO International Value ETF (GMOI), building on the success of GMO U.S. Quality ETF (QLTY) which exceeded $1 billion in assets under management; these ETFs align with the firm's valuation-driven approach and may indirectly support opportunistic strategies. As of mid-2025, the fund maintains a portfolio with spread duration of 1.2 years, effective duration of 2.1 years, yield to worst of 5.4%, and SEC yield of 5.0%, reflecting ongoing adjustments to fixed income and alternative exposures amid market volatility. GMO continues to innovate through quantitative models and risk diversification, with no major reorganizations or name changes reported for GSOFX in the last 1-2 years.